The potential blunting effect of metformin and/or statin therapy on physical activity-induced associations with HbA1c in type 2 diabetes
| dc.contributor.author | Brady, Emer M | |
| dc.contributor.author | Davies, Melanie J | |
| dc.contributor.author | Henson, Joseph | |
| dc.contributor.author | Redman, Emma | |
| dc.contributor.author | Sargeant, Jack | |
| dc.date.accessioned | 2023-11-23T11:29:45Z | |
| dc.date.available | 2023-11-23T11:29:45Z | |
| dc.date.issued | 2023-11-14 | |
| dc.identifier.citation | Henson, J., Davies, M. J., Brady, E. M., Edwardson, C. L., Hall, A. P., Khunti, K., Redman, E., Rowlands, A. V., Sargeant, J., & Yates, T. (2023). The potential blunting effect of metformin and/or statin therapy on physical activity-induced associations with HbA1c in type 2 diabetes. Journal of diabetes, 10.1111/1753-0407.13495. Advance online publication. https://doi.org/10.1111/1753-0407.13495 | en_US |
| dc.identifier.other | 10.1111/1753-0407.13495 | |
| dc.identifier.uri | http://hdl.handle.net/20.500.12904/17899 | |
| dc.description.abstract | Highlights Our analysis indicates a potential blunting effect of metformin and/or statin therapy on physical activity-induced associations with HbA1c. The benefit of daily physical activity on glycemic control in people with type 2 diabetes is potentially more apparent in those prescribed neither metformin nor statin therapy. As physical activity is rarely prescribed in isolation of other background medications used to manage type 2 diabetes, the results of this analysis may help to maximize interventions delivered through routine clinical care, while allowing for personalization in prescribed physical activity and pharmacotherapy. | |
| dc.description.uri | https://onlinelibrary.wiley.com/doi/10.1111/1753-0407.13495 | en_US |
| dc.language.iso | en | en_US |
| dc.subject | metformin | en_US |
| dc.subject | physical activity | en_US |
| dc.subject | statins | en_US |
| dc.subject | type 2 diabetes | en_US |
| dc.title | The potential blunting effect of metformin and/or statin therapy on physical activity-induced associations with HbA1c in type 2 diabetes | en_US |
| dc.type | Article | en_US |
| rioxxterms.funder | Default funder | en_US |
| rioxxterms.identifier.project | Default project | en_US |
| rioxxterms.version | NA | en_US |
| rioxxterms.versionofrecord | https://doi.org/10.1111/1753-0407.13495 | en_US |
| rioxxterms.type | Journal Article/Review | en_US |
| refterms.panel | Unspecified | en_US |
| html.description.abstract | Highlights Our analysis indicates a potential blunting effect of metformin and/or statin therapy on physical activity-induced associations with HbA1c. The benefit of daily physical activity on glycemic control in people with type 2 diabetes is potentially more apparent in those prescribed neither metformin nor statin therapy. As physical activity is rarely prescribed in isolation of other background medications used to manage type 2 diabetes, the results of this analysis may help to maximize interventions delivered through routine clinical care, while allowing for personalization in prescribed physical activity and pharmacotherapy. | en_US |
| rioxxterms.funder.project | 94a427429a5bcfef7dd04c33360d80cd | en_US |